Stay updated on Lazertinib Combination in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Lazertinib Combination in NSCLC Clinical Trial page.

Latest updates to the Lazertinib Combination in NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe study record revision was updated from v3.5.4 to v3.5.5, indicating a small maintenance update to the record's metadata and backend data. This update does not imply changes to the described study details.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page revision has been updated from v3.5.3 to v3.5.4, indicating a small platform or content-management update rather than a change to the study information.SummaryDifference0.0%

- Check23 days agoChange DetectedAdded a Publications entry for the CHRYSALIS-2 Cohort A paper with full author details. Corrected the Köln collaborator location by replacing the misspelled entry with the proper 'Kliniken der Stadt Köln gGmbH, Krankenhaus Köln-Mehrheim' and removed the erroneous version.SummaryDifference0.3%

- Check38 days agoChange DetectedThe page's revision line was updated from v3.5.2 to v3.5.3. This indicates a new revision of the page content.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page footer revision label was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check52 days agoChange DetectedThe study record shows updates in April 2026, with the latest posting dated 2026-04-13. These changes appear to be metadata updates rather than substantive changes to the study's design or results.SummaryDifference0.1%

Stay in the know with updates to Lazertinib Combination in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lazertinib Combination in NSCLC Clinical Trial page.